Literature DB >> 2451132

A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

M Yanagisawa1, H Kurihara, S Kimura, Y Tomobe, M Kobayashi, Y Mitsui, Y Yazaki, K Goto, T Masaki.   

Abstract

An endothelium-derived 21-residue vasoconstrictor peptide, endothelin, has been isolated, and shown to be one of the most potent vasoconstrictors known. Cloning and sequencing of preproendothelin complementary DNA shows that mature endothelin is generated through an unusual proteolytic processing, and regional homologies to a group of neurotoxins suggest that endothelin is an endogenous modulator of voltage-dependent ion channels. Expression of the endothelin gene is regulated by several vasoactive agents, indicating the existence of a novel cardiovascular control system.

Mesh:

Substances:

Year:  1988        PMID: 2451132     DOI: 10.1038/332411a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1590 in total

1.  ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway.

Authors:  A M Evans; H J Cobban; G F Nixon
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  The cutaneous vasoconstrictor response to venous stasis is normal in subjects with primary Raynaud's disease.

Authors:  C M Edwards; J M Marshall; M Pugh
Journal:  Clin Auton Res       Date:  1999-10       Impact factor: 4.435

Review 3.  Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction.

Authors:  G Burnstock
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

4.  Pharmacological characterization of endothelin receptor subtypes in the guinea-pig prostate gland.

Authors:  W A Lau; S L Cox; J N Pennefather; F J Mitchelson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 5.  The anti-inflammatory effects of macrolides.

Authors:  D Wales; M Woodhead
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

6.  Reversal of the vasoconstrictor step of hyperacute xenogeneic rejection of the liver by endothelin antagonists.

Authors:  B Zhang; L Wen; A Gomola; P P Massault; B Cherruau; D Houssin; B Weill; Y Calmus
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

7.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 8.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 9.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

10.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.